Compare FBIN & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FBIN | GRFS |
|---|---|---|
| Founded | 1988 | 1940 |
| Country | United States | Spain |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.2B |
| IPO Year | 2011 | 2008 |
| Metric | FBIN | GRFS |
|---|---|---|
| Price | $42.55 | $7.79 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 11 | 2 |
| Target Price | ★ $54.60 | $10.15 |
| AVG Volume (30 Days) | ★ 2.1M | 332.2K |
| Earning Date | 05-07-2026 | 07-28-2022 |
| Dividend Yield | ★ 2.58% | 1.80% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $4,463,200,000.00 | N/A |
| Revenue This Year | $2.68 | $4.49 |
| Revenue Next Year | $3.60 | $6.42 |
| P/E Ratio | $4,311.00 | ★ $18.67 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $32.34 | $6.96 |
| 52 Week High | $64.84 | $10.23 |
| Indicator | FBIN | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 36.37 | 48.17 |
| Support Level | $40.36 | $7.66 |
| Resistance Level | $42.63 | $8.36 |
| Average True Range (ATR) | 1.30 | 0.18 |
| MACD | -0.27 | -0.03 |
| Stochastic Oscillator | 14.52 | 18.49 |
Fortune Brands is a US-based homebuilding products company that sells building-related products serving R&R and new construction markets. The company operates in three segments: water, outdoors, and security. Water innovation, including plumbing fixtures and faucets, accounts for around 55% of total sales and features brands such as Moen, House of Rohl, and Aqualisa. The outdoors segment includes decking, railing, and doors and makes up 30% of total sales, featuring brands such as Larson, Fiberon, and Therma-Tru. The security segment, which includes smart residential padlocks, accounts for the remaining 15% of sales and features brands such as MasterLock, SentrySafe, Yale, and AmericanLock.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.